Engineering Machinery Molecules to Visualize and Reprogram Immunotherapy Abstract Adoptive immunotherapy has the potential to become a paradigm shifting technology for cancer therapy. Specifically, cell based immunotherapy has demonstrated phenomenal success in clinical trials against various malignancies. Although promising, a high degree of precise control of engineered immunocells in targeting tumor cells is needed before the cell-based therapy can become widely adopted. Synthetic biology is an emerging field with the overall goal to understand and manipulate life processes using an engineering approach, particularly molecular engineering. Naturally occurring molecules and domains can be modulated and integrated to produce regulatory modules and molecular machines with well controlled functions. This will allow the engineering of controllable machinery molecules capable of detecting antigens/biomarkers to activate cellular immuno- responses. Biosensors based on fluorescence resonance energy transfer (FRET) have revolutionized the biomedical research by allowing direct visualization and characterization of molecular activities in live cells. The functionality and efficacy of the machinery molecules as well as their modular components can hence be precisely characterized by FRET biosensors serving as ?digital multimeters? to provide immediate feedbacks for the optimization of the sophisticated machinery molecules.
We aim to engineer integrated machinery molecules which can provide a surveillance of the intracellular space, visualizing the spatiotemporal patterns of specific biochemical events and automatically triggering molecular actions to guide immuno-cell functions. We have adopted a modular assembly approach to develop a machinery molecule, specifically for the sensing of intracellular phosphorylation and consequent activation of a tyrosine phosphatase (PTP) Shp2, which plays a critical role in various pathophysiological processes. We have further integrated this machinery molecule to the ?don't eat me? CD47 receptor SIRP? in macrophages such that the engagement of SIRP? and its activation of naturally negative signals will be rewired to turn on a positive Shp2 action to activate the engineered macrophages and facilitate phagocytosis initiated by an anti-gen-targeting antibody and its interaction with Fc? receptors. In this proposal, we plan to apply this strategy to re-engineer macrophages for the eradication of tumors. We choose colon cancer in which cells express a high level of CD47 as our first proof-of-concept target.
Two specific aims are accordingly proposed:
Specific Aim 1. Characterize the phagocytic efficiency and its associated FRET signals of re-engineered macrophages against colon cancer cells.
Specific Aim 2. Examine the efficiency of re-engineered macrophages in eradicating the colon tumors in nude and immunocompetent mouse models. Our platform is designed to be highly modular, with each functional module readily switchable to rewire the molecular network. The platform allows new mode of tumor eradication, with a switchable antibody interface for the eradiation, in principle, any type of tumors. Our engineered macrophage can also be combined with traditional radiotherapy and chemotherapy approaches as well as the immunotherapy antibody methods mitigating the immuno-inhibitory PD-1 and CTLA-4 signals. Vitamin D analog in modulating stromal cells, and the hyaluronic acid (HA) signaling inhibitor PEGPH20 in promoting extracellular matrix (ECM) depletion and tumor vascularity can modulate tumor microenvironment. These existing methods can also be combined together with our engineered macrophage approach to improve the therapeutic efficiency of tumor immunotherapy. Therefore, the success of the proposed approach will revolutionize the ability to perform cell-based immunotherapy and highlight the translational power in bridging the fundamental molecular engineering to clinical medicine.

Public Health Relevance

We propose to develop a controllable machinery molecule to re-engineer macrophages for the cell-based immunotherapy. The resulted technology will provide powerful tools to eradicate tumors and other diseases. The developed genetic modules and FRET biosensors will also be very useful for the study and manipulation of cellular functions for biology and medicine.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Exploratory/Developmental Grants (R21)
Project #
5R21CA209629-02
Application #
9450490
Study Section
Special Emphasis Panel (ZCA1)
Program Officer
Sommers, Connie L
Project Start
2017-03-08
Project End
2019-02-28
Budget Start
2018-03-01
Budget End
2019-02-28
Support Year
2
Fiscal Year
2018
Total Cost
Indirect Cost
Name
University of California, San Diego
Department
Engineering (All Types)
Type
Schools of Arts and Sciences
DUNS #
804355790
City
La Jolla
State
CA
Country
United States
Zip Code
92093
Pan, Yijia; Yoon, Sangpil; Zhu, Linshan et al. (2018) Acoustic mechanogenetics. Curr Opin Biomed Eng 7:64-70
Pan, Yijia; Yoon, Sangpil; Sun, Jie et al. (2018) Mechanogenetics for the remote and noninvasive control of cancer immunotherapy. Proc Natl Acad Sci U S A 115:992-997
Peng, Qin; Lu, Shaoying; Shi, Yuxin et al. (2018) Coordinated histone modifications and chromatin reorganization in a single cell revealed by FRET biosensors. Proc Natl Acad Sci U S A 115:E11681-E11690
Yoon, Sangpil; Wang, Pengzhi; Peng, Qin et al. (2017) Acoustic-transfection for genomic manipulation of single-cells using high frequency ultrasound. Sci Rep 7:5275
Wan, Qiaoqiao; TruongVo, ThucNhi; Steele, Hannah E et al. (2017) Subcellular domain-dependent molecular hierarchy of SFK and FAK in mechanotransduction and cytokine signaling. Sci Rep 7:9033
Sun, Jie; Lei, Lei; Tsai, Chih-Ming et al. (2017) Engineered proteins with sensing and activating modules for automated reprogramming of cellular functions. Nat Commun 8:477
Seong, Jihye; Huang, Min; Sim, Kyoung Mi et al. (2017) FRET-based Visualization of PDGF Receptor Activation at Membrane Microdomains. Sci Rep 7:1593
Han, Yue; Wang, Lu; Yao, Qing-Ping et al. (2015) Nuclear envelope proteins Nesprin2 and LaminA regulate proliferation and apoptosis of vascular endothelial cells in response to shear stress. Biochim Biophys Acta 1853:1165-73
Sun, Chen; Ouyang, Mingxing; Cao, Zhenning et al. (2014) Electroporation-delivered fluorescent protein biosensors for probing molecular activities in cells without genetic encoding. Chem Commun (Camb) 50:11536-9